Zobrazeno 1 - 10
of 19
pro vyhledávání: '"J. Adam Best"'
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
PyMT tumor versus spleen fold change, acute infection day 6 versus spleen fold change.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46a8ba9b195fb816397409fa0c6e1b70
https://doi.org/10.1158/2326-6066.22537717
https://doi.org/10.1158/2326-6066.22537717
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
Selected phosphatases up-regulated in PyMT tumor CD8+ T cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820700add58d7f6b53aa9dfc7f45fb9e
https://doi.org/10.1158/2326-6066.22537705.v1
https://doi.org/10.1158/2326-6066.22537705.v1
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
PyMT tumor CD8+ versus day 5 effector OT-I gene expression and fold change.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f83392c9f161140201446feeb0b064
https://doi.org/10.1158/2326-6066.22537723
https://doi.org/10.1158/2326-6066.22537723
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
Despite clinical potential and recent advances, durable immunotherapeutic ablation of solid tumors is not routinely achieved. IL15 expands natural killer cell (NK), natural killer T cell (NKT) and CD8+ T-cell numbers and engages the cytotoxic program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b950fdf94633ed97d2bceaa098bc4d01
https://doi.org/10.1158/2326-6066.c.6548530.v1
https://doi.org/10.1158/2326-6066.c.6548530.v1
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
PyMT tumor CD8+ versus day 1 effector OT-I gene expression and fold change.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643f73d85a2f51848e9e98995b1eb8a0
https://doi.org/10.1158/2326-6066.22537726.v1
https://doi.org/10.1158/2326-6066.22537726.v1
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
Supplemental Figure 1: Five day IL-15cx treatment results in splenic CD8+ T cell activation and up-regulation of cytotoxic molecule expression in PyMT tumor-bearing mice. Supplemental Figure 2: PyMT tumor single-cell suspensions induce IL-2 / IL-15 r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a78216c1551b9f8f80d3da972c28c6
https://doi.org/10.1158/2326-6066.22537732.v1
https://doi.org/10.1158/2326-6066.22537732.v1
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
Transcripts up-regulated {greater than or equal to}2-fold in PyMT tumor versus splenic CD8+ T cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3111e97a4fd65e74facf081533861fb8
https://doi.org/10.1158/2326-6066.22537714
https://doi.org/10.1158/2326-6066.22537714
Autor:
Ananda W. Goldrath, Jack D. Bui, David J. Cole, Megan K. Baker, David H. Craig, J. Adam Best, Emilie T. Gross, Mark P. Rubinstein, Andrew L. Doedens
PyMT tumor CD8+ versus naive gene expression and fold change.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e142053b10e5e42f8965c70a8350f00
https://doi.org/10.1158/2326-6066.22537729
https://doi.org/10.1158/2326-6066.22537729
Autor:
J Adam Best, Agata Stryjewska, Luca Gattinoni, Ananda W. Goldrath, Jessica V. Nguyen, Yujiro Higashi, Steven Goossens, Kyla D. Omilusik, Danny Huylebroeck, Eve Seuntjens, Rahul Roychoudhuri, Lynne M. Bird, Christiane Zweier, Hisato Kondoh, Jody J. Haigh, Alexander Weidemann, Bingfei Yu
Publikováno v:
The Journal of Experimental Medicine
JOURNAL OF EXPERIMENTAL MEDICINE
The Journal of experimental medicine, vol 212, iss 12
Journal of Experimental Medicine, 212(12), 2027-2039. Rockefeller University Press
JOURNAL OF EXPERIMENTAL MEDICINE
The Journal of experimental medicine, vol 212, iss 12
Journal of Experimental Medicine, 212(12), 2027-2039. Rockefeller University Press
In response to viral infections, activated CD8+ T cells differentiate into terminal effector and memory T cells. This developmental process is controlled by the transcriptional repressor Zeb2, which acts downstream of T-bet.
ZEB2 is a multi-zinc
ZEB2 is a multi-zinc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d9791558e97224378158a0f7f0b00a
http://europepmc.org/articles/PMC4647262
http://europepmc.org/articles/PMC4647262
Autor:
Ananda W. Goldrath, Yan Xing, Sara E. Hamilton, J Adam Best, Ross B. Fulton, Stephen C. Jameson, Kristin A. Hogquist
Publikováno v:
Nature Immunology. 16:107-117
The strength with which complexes of self peptide and major histocompatibility complex (MHC) proteins are recognized by the T cell antigen receptor (TCR) dictates the homeostasis of naive CD8(+) T cells, but its effect on reactivity to foreign antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66f9db8ca4f6f4887e54861bb9258ed
https://doi.org/10.1038/ni.3043
https://doi.org/10.1038/ni.3043